Today's proposal to
increase those
fees by $ 1 billion may not
sound ominous in itself, but it implies an impending, equivalent cut to federal funding, says Steven Grossman, deputy executive director at the Alliance for a Stronger FDA in Washington, D.C.. That's an unrealistic expectation, he adds, because drug companies have already gone through negotiations and reached an agreement with FDA on user
fee increases.
That may not
sound like much, but lowering annual
fees by half a percentage point over the course of a career and a long retirement can boost the size of your nest egg by 25 % and
increase the sustainable income it generates by upwards of 40 %.